Genetron Health to Participate in the Goldman Sachs Healthcare Corporate Day
BEIJING, June 16, 2022 (GLOBE NEWSWIRE) -- Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will be participating in the virtual Goldman Sachs Healthcare Corporate Day.
Genetron’s management team, Sizhen Wang, co-founder and Chief Executive Officer and Evan Xu, Chief Financial Officer, will attend investor meetings on Friday, June 24, 2022.
Interested parties may request more information by contacting their sales representative at Goldman Sachs.
About Genetron Holdings Limited
Safe Harbor Statement
Investor Relations Contact